BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 17630319)

  • 1. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease.
    Hodge S; Hodge G; Ahern J; Jersmann H; Holmes M; Reynolds PN
    Am J Respir Cell Mol Biol; 2007 Dec; 37(6):748-55. PubMed ID: 17630319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease.
    Hodge S; Hodge G; Jersmann H; Matthews G; Ahern J; Holmes M; Reynolds PN
    Am J Respir Crit Care Med; 2008 Jul; 178(2):139-48. PubMed ID: 18420960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages.
    Hodge S; Hodge G; Brozyna S; Jersmann H; Holmes M; Reynolds PN
    Eur Respir J; 2006 Sep; 28(3):486-95. PubMed ID: 16737992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic role for mannose-binding lectin in cigarette smoke-induced lung inflammation? Evidence from a murine model.
    Hodge S; Matthews G; Dean MM; Ahern J; Djukic M; Hodge G; Jersmann H; Holmes M; Reynolds PN
    Am J Respir Cell Mol Biol; 2010 Feb; 42(2):235-42. PubMed ID: 19411612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary disease subjects.
    Hodge S; Reynolds PN
    Respirology; 2012 Jul; 17(5):802-7. PubMed ID: 22288725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients.
    Droemann D; Goldmann T; Tiedje T; Zabel P; Dalhoff K; Schaaf B
    Respir Res; 2005 Jul; 6(1):68. PubMed ID: 16004610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.
    Löfdahl JM; Wahlström J; Sköld CM
    Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD).
    Barnawi J; Tran H; Jersmann H; Pitson S; Roscioli E; Hodge G; Meech R; Haberberger R; Hodge S
    PLoS One; 2015; 10(10):e0122771. PubMed ID: 26485657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine.
    Hodge S; Matthews G; Mukaro V; Ahern J; Shivam A; Hodge G; Holmes M; Jersmann H; Reynolds PN
    Am J Respir Cell Mol Biol; 2011 May; 44(5):673-81. PubMed ID: 20595463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD.
    Ween MP; White JB; Tran HB; Mukaro V; Jones C; Macowan M; Hodge G; Trim PJ; Snel MF; Hodge SJ
    Sci Rep; 2021 Feb; 11(1):4106. PubMed ID: 33602992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
    Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
    Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1 antitrypsin supplementation improves alveolar macrophages efferocytosis and phagocytosis following cigarette smoke exposure.
    Serban KA; Petrusca DN; Mikosz A; Poirier C; Lockett AD; Saint L; Justice MJ; Twigg HL; Campos MA; Petrache I
    PLoS One; 2017; 12(4):e0176073. PubMed ID: 28448535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease.
    Tsoumakidou M; Bouloukaki I; Koutala H; Kouvidi K; Mitrouska I; Zakynthinos S; Tzanakis N; Jeffery PK; Siafakas NM
    Int Arch Allergy Immunol; 2009; 150(4):389-97. PubMed ID: 19571571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
    Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
    COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease.
    Rusznak C; Mills PR; Devalia JL; Sapsford RJ; Davies RJ; Lozewicz S
    Am J Respir Cell Mol Biol; 2000 Oct; 23(4):530-6. PubMed ID: 11017919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Airway inflammation and lymphocyte subset analysis in patients with chronic obstructive pulmonary disease and healthy smokers].
    Yurdakul AS; Taci Hoca N; Cimen F; Atikcan S; Sipit T; Atasever M; Balci M
    Tuberk Toraks; 2006; 54(2):122-7. PubMed ID: 16924567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease.
    Suzuki M; Betsuyaku T; Ito Y; Nagai K; Nasuhara Y; Kaga K; Kondo S; Nishimura M
    Am J Respir Cell Mol Biol; 2008 Dec; 39(6):673-82. PubMed ID: 18566336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
    Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
    COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
    Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
    Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The expressions of nerve growth factor and its tyrosine kinase A receptor on alveolar macrophages in a rat model of chronic obstructive pulmonary disease].
    Li MM; Xin XF; Shao HT; Shi Y; Su X; Sun WK; Sun H; Fang LP
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Aug; 35(8):601-5. PubMed ID: 23158009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.